Skip to content

Sound therapy for tinnitus relief for adult cochlear-implant users

Functional impact of tinnitus in post-lingual users of cochlear implants and short-term effects of sound therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15705814
Enrollment
60
Registered
2019-10-14
Start date
2019-12-01
Completion date
Unknown
Last updated
2022-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus Nervous System Diseases Tinnitus

Interventions

While Part A of the study seeks to explore objective measures of tinnitus, Part B seeks to assess the effect of sound therapy on tinnitus. In Part B, participants will be asked to com

Sponsors

Jointly sponsored by the University of Cambridge and Cambridge University NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Part A: 1. Adult (aged 18+ years, with no upper limit) 2. Users of unilateral cochlear implants 3. Fluent in English 4. Attend the Emmeline Centre for Auditory Implants 5. Had their cochlear implants switched on for at least one year Part B: 1. Adult (aged 18+ years) 2. Users of unilateral cochlear implants 3. Attend the Emmeline Centre for Auditory Implants 4. Had their cochlear implants switched on for at least one year 5. Have tinnitus even when their cochlear implant is switched on 6. Scored 32 or higher in the Tinnitus Functional Index questionnaire

Exclusion criteria

Exclusion criteria: Part A and B: 1. Bilateral cochlear implantation 2. Aged less than 18 years 3. Severe visual impairment 4. Severe mental-health condition 5. Severe general-health condition 6. Currently having medication that affects tinnitus or the recording of evoked potentials Additionally, for Part B: 7. Currently receiving other treatments for tinnitus apart from tinnitus management therapy

Design outcomes

Primary

MeasureTime frame
Part A: 1. Mismatch negativity: Variables are amplitude, latency, and area under the curve 2. Auditory Steady State Response and N1-P2 responses: The variable is amplitude in each case. 3. P300: The variables are amplitude and latency For all of these outcome measures (1, 2, and 3), the method of measurement is recording event-related auditory evoked potentials 4. Pupillometry: The variable is Pupillar diameter. The method of measurement is pupillometry Part B: 5. Tinnitus loudness ratings. Methods: Subjective ratings in a visual-analogue scale 6. Tinnitus annoyance ratings. Methods: Subjective ratings in a visual-analogue scale 7. One objective measure selected based on the outcomes of Part A. It could be 1, 2, 3, or 4. The measure with the highest sensitivity to separate between participants with tinnitus and without tinnitus will be used

Secondary

MeasureTime frame
Part A: 1. Variable: Tinnitus Functional Index; Method: validated questionnaire 2. Variable: Qualitative data describing each participant's tinnitus. Method: Tinnitus Cochlear Implant Questionnaire, non validated questionnaire 3. Variable: Tinnitus Loudness Ratings; Methods: Subjective ratings in a visual-analogue scale

Countries

England, United Kingdom

Contacts

Public ContactMarina Salorio-Corbetto
ms878@cam.ac.uk+44 (0)1223746454

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026